OppenheimerFunds’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-620,000
Closed -$5.53M 1946
2016
Q4
$5.53M Buy
620,000
+200,000
+48% +$2.02M 0.01% 824
2016
Q3
$5.07M Buy
420,000
+173,779
+71% +$2.34M 0.01% 821
2016
Q2
$3.2M Buy
+246,221
New +$2.29M ﹤0.01% 837
2014
Q2
Sell
-404,830
Closed -$4.02M 1030
2014
Q1
$4.02M Buy
+404,830
New +$3.8M ﹤0.01% 850

Other funds holding SSRI

OppenheimerFunds's SSRI Position: Q1 2017 in Review

OppenheimerFunds sold out of Silver Standard Resources (SSRI) in Q1 2017, closing a stake of 620,000 shares — an estimated $5.53M sold.

OppenheimerFunds first reported a position in SSRI in Q1 2014 and held it in 4 quarters. The position peaked at $5.53M in Q4 2016. 124 funds tracked by Wall St. Rank hold SSRI as of Q1 2017.

  • OppenheimerFunds reported no remaining Silver Standard Resources position as of Q1 2017 after selling out during the quarter.
  • OppenheimerFunds sold 620,000 Silver Standard Resources shares in Q1 2017, an estimated $5.53M.
  • OppenheimerFunds first reported a position in Silver Standard Resources in Q1 2014 and held it in 4 quarters.
  • OppenheimerFunds's Silver Standard Resources position peaked at $5.53M in Q4 2016.
  • 124 funds tracked by Wall St. Rank held Silver Standard Resources as of Q1 2017.

Based on OppenheimerFunds's 13F filing for Q1 2017, filed 11 May 2017.